Filing Details
- Accession Number:
- 0001209191-20-043953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-29 17:29:58
- Reporting Period:
- 2020-07-28
- Accepted Time:
- 2020-07-29 17:29:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1693011 | Inozyme Pharma Inc. | INZY | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-28 | 2,194,379 | $0.00 | 2,194,379 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-07-28 | 375,000 | $16.00 | 2,569,379 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A CONVERTIBLE PREFERRED STOCK | Disposition | 2020-07-28 | 15,000,000 | $0.00 | 2,007,225 | $0.00 |
| Common Stock | SERIES A-2 CONVERTIBLE PREFERRED STOCK | Disposition | 2020-07-28 | 1,398,600 | $0.00 | 187,154 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Convertible Preferred Stock and Series A-2 Convertible Preferred Stock automatically converted on a 7.4730-for-1 basis into the number of shares of Common Stock as shown in Column 7 upon the closing of the Issuer's initial public offering without payment or further consideration. These shares have no expiration date.
- Represents a purchase from the underwriters in the Issuer's initial public offering.
Billionaire Hedge Funds
